• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用双参数最小二乘法拟合提高 ADPKD 患者总肾体积增长率的预测。

Improved predictions of total kidney volume growth rate in ADPKD using two-parameter least squares fitting.

机构信息

Department of Radiology, Weill Cornell Medicine, New York, 10022, USA.

The Rogosin Institute, New York, 10021, USA.

出版信息

Sci Rep. 2024 Jun 14;14(1):13794. doi: 10.1038/s41598-024-62776-8.

DOI:10.1038/s41598-024-62776-8
PMID:38877066
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11178802/
Abstract

Mayo Imaging Classification (MIC) for predicting future kidney growth in autosomal dominant polycystic kidney disease (ADPKD) patients is calculated from a single MRI/CT scan assuming exponential kidney volume growth and height-adjusted total kidney volume at birth to be 150 mL/m. However, when multiple scans are available, how this information should be combined to improve prediction accuracy is unclear. Herein, we studied ADPKD subjects ( ) with 8+ years imaging follow-up (mean = 11 years) to establish ground truth kidney growth trajectory. MIC annual kidney growth rate predictions were compared to ground truth as well as 1- and 2-parameter least squares fitting. The annualized mean absolute error in MIC for predicting total kidney volume growth rate was compared to ( ) for a 2-parameter fit to the same exponential growth curve used for MIC when 4 measurements were available or ( ) with 3 measurements averaging together with MIC. On univariate analysis, male sex ( ) and PKD2 mutation ( ) were associated with poorer MIC performance. In ADPKD patients with 3 or more CT/MRI scans, 2-parameter least squares fitting predicted kidney volume growth rate better than MIC, especially in males and with PKD2 mutations where MIC was less accurate.

摘要

梅奥影像学分类(MIC)用于预测常染色体显性多囊肾病(ADPKD)患者未来的肾脏生长,其计算基于单次 MRI/CT 扫描,假设肾脏体积呈指数增长,出生时身高校正的总肾脏体积为 150 mL/m。然而,当有多份扫描结果时,如何结合这些信息以提高预测准确性尚不清楚。在此,我们研究了具有 8 年以上影像学随访(平均 11 年)的 ADPKD 患者(),以建立真实的肾脏生长轨迹。将 MIC 的年度肾脏生长率预测与真实值以及 1 参数和 2 参数最小二乘法拟合进行比较。MIC 预测总肾脏体积增长率的年化平均绝对误差为,而当有 4 次测量值时,2 参数拟合相同的 MIC 所使用的指数生长曲线的平均绝对误差为,当有 3 次测量值与 MIC 一起平均时的平均绝对误差为。单因素分析显示,男性()和 PKD2 突变()与 MIC 性能较差相关。在有 3 次或更多 CT/MRI 扫描的 ADPKD 患者中,2 参数最小二乘法拟合预测肾脏体积增长率优于 MIC,尤其是在男性和 PKD2 突变患者中,MIC 准确性较差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c5b/11178802/8811db919d34/41598_2024_62776_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c5b/11178802/91d926136fab/41598_2024_62776_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c5b/11178802/7a21e7541f2c/41598_2024_62776_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c5b/11178802/8811db919d34/41598_2024_62776_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c5b/11178802/91d926136fab/41598_2024_62776_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c5b/11178802/7a21e7541f2c/41598_2024_62776_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c5b/11178802/8811db919d34/41598_2024_62776_Fig3_HTML.jpg

相似文献

1
Improved predictions of total kidney volume growth rate in ADPKD using two-parameter least squares fitting.使用双参数最小二乘法拟合提高 ADPKD 患者总肾体积增长率的预测。
Sci Rep. 2024 Jun 14;14(1):13794. doi: 10.1038/s41598-024-62776-8.
2
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
3
Development and Validation of a Convolutional Neural Network Model to Predict a Pathologic Fracture in the Proximal Femur Using Abdomen and Pelvis CT Images of Patients With Advanced Cancer.利用晚期癌症患者腹部和骨盆 CT 图像建立卷积神经网络模型预测股骨近端病理性骨折的研究
Clin Orthop Relat Res. 2023 Nov 1;481(11):2247-2256. doi: 10.1097/CORR.0000000000002771. Epub 2023 Aug 23.
4
Polycystic Kidney Disease, Autosomal Dominant常染色体显性多囊肾病
5
Interventions for preventing the progression of autosomal dominant polycystic kidney disease.用于预防常染色体显性遗传性多囊肾病进展的干预措施。
Cochrane Database Syst Rev. 2024 Oct 2;10(10):CD010294. doi: 10.1002/14651858.CD010294.pub3.
6
Interventions for preventing the progression of autosomal dominant polycystic kidney disease.预防常染色体显性多囊肾病进展的干预措施。
Cochrane Database Syst Rev. 2015 Jul 14;2015(7):CD010294. doi: 10.1002/14651858.CD010294.pub2.
7
Volume Reduction in Enlarged Kidneys in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Prior to Renal Transplant with Transcatheter Arterial Embolization (TAE): A Systematic Review and Meta-Analysis.肾移植前经导管动脉栓塞术(TAE)治疗常染色体显性多囊肾病(ADPKD)肿大肾脏的体积缩小:一项系统评价和荟萃分析
Cardiovasc Intervent Radiol. 2018 Jun;41(6):828-834. doi: 10.1007/s00270-018-1890-7. Epub 2018 Jan 31.
8
Does the Presence of Missing Data Affect the Performance of the SORG Machine-learning Algorithm for Patients With Spinal Metastasis? Development of an Internet Application Algorithm.缺失数据的存在是否会影响 SORG 机器学习算法在脊柱转移瘤患者中的性能?开发一种互联网应用算法。
Clin Orthop Relat Res. 2024 Jan 1;482(1):143-157. doi: 10.1097/CORR.0000000000002706. Epub 2023 Jun 12.
9
Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.超声造影使用声诺维®(六氟化硫微泡)与对比增强计算机断层扫描和对比增强磁共振成像在局灶性肝脏病变的特征描述和肝转移检测中的比较:系统评价和成本效益分析。
Health Technol Assess. 2013 Apr;17(16):1-243. doi: 10.3310/hta17160.
10
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.

引用本文的文献

1
Comparison Between the Human-Sourced Ellipsoid Method and Kidney Volumetry Using Artificial Intelligence in Polycystic Kidney Disease.多囊肾病中人源椭球体法与人工智能肾脏体积测量法的比较
J Pers Med. 2025 Aug 20;15(8):392. doi: 10.3390/jpm15080392.
2
The Role of Baseline Total Kidney Volume Growth Rate in Predicting Tolvaptan Efficacy for ADPKD Patients: A Feasibility Study.基线总肾体积增长率在预测托伐普坦对常染色体显性多囊肾病患者疗效中的作用:一项可行性研究
J Clin Med. 2025 Feb 21;14(5):1449. doi: 10.3390/jcm14051449.
3
Multisystemic impact of autosomal dominant polycystic kidney disease: A case report highlighting renal, hepatic, and neurological involvement.

本文引用的文献

1
An Artificial Intelligence Generated Automated Algorithm to Measure Total Kidney Volume in ADPKD.一种用于测量常染色体显性多囊肾病中总肾体积的人工智能生成的自动化算法。
Kidney Int Rep. 2023 Nov 4;9(2):249-256. doi: 10.1016/j.ekir.2023.10.029. eCollection 2024 Feb.
2
Comparing Effects of Tolvaptan and Instruction to Increase Water Consumption in ADPKD: Post Hoc Analysis of TEMPO 3:4.比较托伐普坦和增加水分摄入对 ADPKD 的效果:TEMPO 3:4 的事后分析。
Kidney360. 2023 Dec 1;4(12):1702-1707. doi: 10.34067/KID.0000000000000302. Epub 2023 Nov 21.
3
Test Retest Reproducibility of Organ Volume Measurements in ADPKD Using 3D Multimodality Deep Learning.
常染色体显性多囊肾病的多系统影响:一例突出肾脏、肝脏和神经受累的病例报告。
Radiol Case Rep. 2025 Jan 30;20(4):2093-2100. doi: 10.1016/j.radcr.2025.01.021. eCollection 2025 Apr.
使用 3D 多模态深度学习评估 ADPKD 中器官体积测量的测试-重测可重复性。
Acad Radiol. 2024 Mar;31(3):889-899. doi: 10.1016/j.acra.2023.09.009. Epub 2023 Oct 3.
4
How to Estimate Kidney Growth in Patients with Autosomal Dominant Polycystic Kidney Disease.如何评估常染色体显性多囊肾病患者的肾脏生长情况。
J Am Soc Nephrol. 2023 Jun 1;34(6):944-950. doi: 10.1681/ASN.0000000000000130. Epub 2023 Mar 30.
5
Clinical Implementation of an Artificial Intelligence Algorithm for Magnetic Resonance-Derived Measurement of Total Kidney Volume.磁共振衍生全肾体积测量人工智能算法的临床应用。
Mayo Clin Proc. 2023 May;98(5):689-700. doi: 10.1016/j.mayocp.2022.12.019. Epub 2023 Mar 16.
6
Atypical Polycystic Kidney Disease as defined by Imaging.影像学定义的非典型多囊肾病。
Sci Rep. 2023 Feb 20;13(1):2952. doi: 10.1038/s41598-022-24104-w.
7
Risk Severity Model for Pediatric Autosomal Dominant Polycystic Kidney Disease Using 3D Ultrasound Volumetry.基于 3D 超声体积测量的儿童常染色体显性遗传性多囊肾病严重程度风险模型
Clin J Am Soc Nephrol. 2023 May 1;18(5):581-591. doi: 10.2215/CJN.0000000000000122. Epub 2023 Feb 17.
8
Current Challenges and Perspectives on Developing a Clinical Trial Design for ADPKD.成人多囊肾病临床试验设计的当前挑战与展望
Clin J Am Soc Nephrol. 2022 Oct;17(10):1559-1562. doi: 10.2215/CJN.05360522. Epub 2022 Aug 23.
9
Deep Learning Automation of Kidney, Liver, and Spleen Segmentation for Organ Volume Measurements in Autosomal Dominant Polycystic Kidney Disease.深度学习自动化分割肾脏、肝脏和脾脏,用于常染色体显性多囊肾病的器官体积测量。
Tomography. 2022 Jul 13;8(4):1804-1819. doi: 10.3390/tomography8040152.
10
Deep Learning-Based Total Kidney Volume Segmentation in Autosomal Dominant Polycystic Kidney Disease Using Attention, Cosine Loss, and Sharpness Aware Minimization.基于深度学习的常染色体显性多囊肾病全肾体积分割:使用注意力机制、余弦损失和锐度感知最小化
Diagnostics (Basel). 2022 May 7;12(5):1159. doi: 10.3390/diagnostics12051159.